The anti-cyclic citrullinated peptide (Anti-CCP IgG) test is used to detect antibodies associated with rheumatoid arthritis, and it is one of the most accurate tests for diagnosing this disease in its early stages. This analysis helps identify patients who may be at higher risk of developing long-term complications and also assists in distinguishing rheumatoid arthritis from other autoimmune diseases.